These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35123004)

  • 1. Design, synthesis and molecular docking studies of imidazole and benzimidazole linked ethionamide derivatives as inhibitors of InhA and antituberculosis agents.
    Raghu MS; Pradeep Kumar CB; Yogesh Kumar K; Prashanth MK; Alshahrani MY; Ahmad I; Jain R
    Bioorg Med Chem Lett; 2022 Mar; 60():128604. PubMed ID: 35123004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analogues of ethionamide, a drug used for multidrug-resistant tuberculosis, exhibit potent inhibition of tyrosinase.
    Choi J; Park SJ; Jee JG
    Eur J Med Chem; 2015 Dec; 106():157-66. PubMed ID: 26544630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Click synthesis of 1,2,3-triazole based imidazoles: Antitubercular evaluation, molecular docking and HSA binding studies.
    Pradeep Kumar CB; Prathibha BS; Prasad KNN; Raghu MS; Prashanth MK; Jayanna BK; Alharthi FA; Chandrasekhar S; Revanasiddappa HD; Yogesh Kumar K
    Bioorg Med Chem Lett; 2021 Mar; 36():127810. PubMed ID: 33482292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Insights into the Chemistry and Antitubercular Potential of Benzimidazole and Imidazole Derivatives.
    Parwani D; Bhattacharya S; Rathore A; Mallick C; Asati V; Agarwal S; Rajoriya V; Das R; Kashaw SK
    Mini Rev Med Chem; 2021; 21(5):643-657. PubMed ID: 33138762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
    Lokesh BVS; Prasad YR; Shaik AB
    Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, molecular docking and anti-mycobacterial evaluation of new imidazo[1,2-a]pyridine-2-carboxamide derivatives.
    Jose G; Suresha Kumara TH; Nagendrappa G; Sowmya HB; Sriram D; Yogeeswari P; Sridevi JP; Guru Row TN; Hosamani AA; Sujan Ganapathy PS; Chandrika N; Narendra LV
    Eur J Med Chem; 2015 Jan; 89():616-27. PubMed ID: 25462270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imidazoquinoline Derivatives as Potential Inhibitors of InhA Enzyme and
    Hoffmann P; Azéma-Despeyroux J; Goncalves F; Stamilla A; Saffon-Merceron N; Rodriguez F; Degiacomi G; Pasca MR; Lherbet C
    Molecules; 2024 Jun; 29(13):. PubMed ID: 38999028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MoS
    Raghu MS; Pradeep Kumar CB; Prasad KNN; Prashanth MK; Kumarswamy YK; Chandrasekhar S; Veeresh B
    ACS Comb Sci; 2020 Oct; 22(10):509-518. PubMed ID: 32806898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and docking studies of some novel (R)-2-(4'-chlorophenyl)-3-(4'-nitrophenyl)-1,2,3,5-tetrahydrobenzo[4,5] imidazo [1,2-c]pyrimidin-4-ol derivatives as antitubercular agents.
    Barot KP; Jain SV; Gupta N; Kremer L; Singh S; Takale VB; Joshi K; Ghate MD
    Eur J Med Chem; 2014 Aug; 83():245-55. PubMed ID: 24972340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of antimycobacterial activity of new benzimidazole aminoesters.
    Yoon YK; Ali MA; Wei AC; Choon TS; Ismail R
    Eur J Med Chem; 2015 Mar; 93():614-24. PubMed ID: 24996257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobacterium enoyl acyl carrier protein reductase (InhA): A key target for antitubercular drug discovery.
    Prasad MS; Bhole RP; Khedekar PB; Chikhale RV
    Bioorg Chem; 2021 Oct; 115():105242. PubMed ID: 34392175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple receptor conformers based molecular docking study of fluorine enhanced ethionamide with mycobacterium enoyl ACP reductase (InhA).
    Khan AM; Shawon J; Halim MA
    J Mol Graph Model; 2017 Oct; 77():386-398. PubMed ID: 28957755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1H-Benzo[d]imidazoles and 3,4-dihydroquinazolin-4-ones: Design, synthesis and antitubercular activity.
    Macchi FS; Pissinate K; Villela AD; Abbadi BL; Rodrigues-Junior V; Nabinger DD; Altenhofen S; Sperotto N; da Silva Dadda A; Subtil FT; de Freitas TF; Erhart Rauber AP; Borsoi AF; Bonan CD; Bizarro CV; Basso LA; Santos DS; Machado P
    Eur J Med Chem; 2018 Jul; 155():153-164. PubMed ID: 29885576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of in vitro antimycobacterial activity of novel 1H-benzo[d]imidazole derivatives and analogues.
    Gobis K; Foks H; Serocki M; Augustynowicz-Kopeć E; Napiórkowska A
    Eur J Med Chem; 2015 Jan; 89():13-20. PubMed ID: 25462221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzimidazoquinazolines as new potent anti-TB chemotypes: Design, synthesis, and biological evaluation.
    Jadhavar PS; Patel KI; Dhameliya TM; Saha N; Vaja MD; Krishna VS; Sriram D; Chakraborti AK
    Bioorg Chem; 2020 Jun; 99():103774. PubMed ID: 32224336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of new imidazo[2,1-b][1,3,4]thiadiazole-benzimidazole derivatives.
    Ramprasad J; Nayak N; Dalimba U; Yogeeswari P; Sriram D; Peethambar SK; Achur R; Kumar HS
    Eur J Med Chem; 2015 May; 95():49-63. PubMed ID: 25794789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and biological evaluation of benzo[d]imidazole-2-carboxamides as new anti-TB agents.
    Dhameliya TM; Patel KI; Tiwari R; Vagolu SK; Panda D; Sriram D; Chakraborti AK
    Bioorg Chem; 2021 Feb; 107():104538. PubMed ID: 33349456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clubbed [1,2,3] triazoles by fluorine benzimidazole: a novel approach to H37Rv inhibitors as a potential treatment for tuberculosis.
    Gill C; Jadhav G; Shaikh M; Kale R; Ghawalkar A; Nagargoje D; Shiradkar M
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6244-7. PubMed ID: 18930654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antituberculosis: synthesis and antimycobacterial activity of novel benzimidazole derivatives.
    Keng Yoon Y; Ashraf Ali M; Choon TS; Ismail R; Chee Wei A; Suresh Kumar R; Osman H; Beevi F
    Biomed Res Int; 2013; 2013():926309. PubMed ID: 24381946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-pot synthesis, spectral characterization, biological evaluation, molecular docking studies and in silico ADME/Tox profiling of new 2,4,5 triaryl imidazole derivatives as anti tubercular agents.
    Munnaluri RK; Chevula J; Patnam N; Yamini L; Manga V
    Indian J Tuberc; 2023 Oct; 70(4):451-459. PubMed ID: 37968051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.